Clinical trial
Neuromodulation and Language Acquisition (Stage Ib)
NCT00102856 · University Hospital Muenster, Other · Suspended
Key facts
| NCT number | NCT00102856 |
|---|---|
| Title | Neuromodulation and Language Acquisition (Stage Ib) |
| Official title | Neuromodulation and Language Acquisition (KS-Neuromod_01, Stage Ib) |
| Lead sponsor | University Hospital Muenster, Other |
| Status | Suspended |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Pramipexole, Rivastigmine |
| Enrollment | 60 |
| Start date | Jan 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Feb 4, 2005 |
| Last update posted | Jun 24, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: